Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $34000.0.

  • Connect Biopharma Holdings' Capital Expenditures fell 7687.07% to $34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $731000.0, marking a year-over-year change of. This contributed to the annual value of $750000.0 for FY2024, which is 82592.59% up from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Capital Expenditures of $34000.0 as of Q3 2025, which was down 7687.07% from $303000.0 recorded in Q2 2025.
  • Connect Biopharma Holdings' 5-year Capital Expenditures high stood at $313000.0 for Q4 2024, and its period low was $34000.0 during Q3 2025.